Get Your Free Guide to UroLift and Medicare Coverage

What is UroLift and How Does It Work?

UroLift is a medical device designed to treat benign prostatic hyperplasia, commonly called BPH or an enlarged prostate. The device itself is a small implant made of nickel-titanium alloy that a urologist places directly into the prostate tissue during an outpatient procedure. Unlike other treatments that remove or destroy prostate tissue, UroLift works by mechanically lifting and holding the enlarged prostate tissue to the side, creating more space in the urethra—the tube that carries urine from the bladder through the prostate and out of the body.

The procedure to place a UroLift implant typically takes about 20 to 30 minutes and is performed in a doctor's office or outpatient surgical center. The urologist uses a special delivery device called a urethroscope to visualize the prostate and position the implants. Most men receive between two and four implants, depending on the size of their prostate and the pattern of obstruction. Each implant is about the size of a small staple, and once in place, it remains permanently in the prostate.

Many men experience symptom improvement relatively quickly. Studies show that symptom improvement can begin within two weeks, with continued improvement over the following weeks. Common benefits reported by patients include increased urinary flow rate, reduced nighttime bathroom visits, less urgency to urinate, and improved quality of life. The procedure does not require general anesthesia, meaning patients can often return home the same day with minimal discomfort and downtime.

UroLift differs from other BPH treatments in important ways. Medications like finasteride or tamsulosin can reduce symptoms but require ongoing use and may take several months to show results. Transurethral resection of the prostate (TURP) is a more invasive surgical procedure that removes prostate tissue. UroLift provides an alternative middle ground—minimally invasive with a single procedure that produces relatively durable results without the risks associated with more extensive surgery.

Practical takeaway: Understanding how UroLift works—as a mechanical lift rather than a removal or destruction of tissue—helps you grasp why it appeals to many men seeking symptom relief without extensive surgery or long-term medication dependence.

Understanding Medicare Coverage for UroLift

Medicare is the federal health insurance program that primarily covers people age 65 and older, as well as some younger people with specific disabilities or conditions. Medicare has four main parts: Part A covers hospital stays, Part B covers doctor visits and outpatient procedures, Part D covers prescription drugs, and Medicare Advantage plans (Part C) are private insurance alternatives approved by Medicare. Understanding which part of Medicare covers UroLift requires knowing how Medicare categorizes this procedure.

UroLift received FDA approval in 2013, and Medicare issued a national coverage determination for the device in 2015. This means Medicare has reviewed the evidence and determined that UroLift may be covered under certain conditions. Specifically, Medicare Part B typically covers UroLift when a urologist performs the procedure in an outpatient setting. Medicare Part B is the medical insurance portion that covers physician services, diagnostic tests, and outpatient procedures—so the UroLift implantation procedure itself generally falls under this coverage category.

However, Medicare coverage is not automatic or universal. Medicare has specific clinical coverage policies that must be met for coverage to apply. These policies exist to ensure the procedure is used appropriately and that beneficiaries meet certain criteria. The coverage policies vary slightly depending on your geographic region, as Medicare contracts with regional contractors who process claims and make some local coverage decisions. This is why your specific coverage situation may differ from someone else's, even if you both have Medicare Part B.

The cost-sharing aspects of Medicare Part B coverage are also important to understand. If your UroLift procedure is covered under Part B, you would generally be responsible for your Part B deductible (which was $226 in 2024) and then 20 percent coinsurance for the procedure and related services. If you have a Medigap supplemental policy or a Medicare Advantage plan, your out-of-pocket costs may be reduced, depending on your specific plan.

Practical takeaway: Medicare Part B generally covers UroLift procedures, but your actual coverage depends on regional policies, whether you meet specific clinical criteria, and what supplemental coverage you have. Contact your regional Medicare contractor or your doctor's office to understand your specific coverage situation.

Medicare's Clinical Coverage Requirements for UroLift

Medicare does not cover every UroLift procedure for every patient. Instead, Medicare has established clinical coverage requirements that a patient must meet for the procedure to be covered under Part B. These requirements are based on clinical evidence and are designed to ensure the procedure is used in cases where it is most likely to be beneficial. Understanding these criteria gives you insight into how Medicare makes coverage decisions.

The primary requirement is a diagnosis of symptomatic benign prostatic hyperplasia. This means you must have an enlarged prostate (confirmed through examination or testing) and you must be experiencing bothersome lower urinary tract symptoms related to that enlargement. These symptoms typically include urinary frequency, urgency, weak urinary stream, hesitancy, nocturia (waking multiple times at night to urinate), or incomplete emptying of the bladder. A simple enlarged prostate without symptoms does not meet the criteria; the symptoms must be present and causing you difficulty.

Another key requirement is that the patient must have failed or declined medical management. Medical management refers to treatment with medications such as alpha-blockers or 5-alpha reductase inhibitors. Medicare generally expects that a patient has either tried these medications and they did not provide adequate symptom relief, or the patient has decided not to take these medications. This requirement recognizes medications as a first-line treatment option. If you have never tried medical therapy and have no reason to decline it, Medicare may not cover UroLift.

Prostate size requirements are also part of coverage criteria in some regions. Medicare coverage policies often specify that the prostate should measure between certain dimensions—typically between 30 and 80 cubic centimeters—to be suitable for UroLift. Prostates that are very small or very large may not be considered appropriate candidates. Your urologist would need to measure your prostate using ultrasound or another imaging method to determine if your prostate falls within the appropriate range for coverage.

Additionally, a patient must have adequate renal function (kidney function) and must not have a post-void residual volume (the amount of urine left in the bladder after urination) that is excessively high. These requirements help ensure the procedure will be safe and effective. Patients with severe kidney disease or extremely high residual volumes may need different treatment approaches. A urologist performing the procedure will typically verify these clinical parameters before recommending UroLift.

Practical takeaway: Medicare coverage for UroLift requires diagnosed symptomatic BPH, a trial of or deliberate decision against medical management, appropriate prostate size, and adequate kidney function. These criteria help determine whether Medicare will cover your procedure; your urologist can assess whether you meet these requirements.

What Information You Should Gather Before Discussing UroLift with Your Doctor

Preparing for a conversation with your urologist about UroLift involves gathering specific medical information and understanding your Medicare coverage. This preparation helps you ask informed questions and understand your options more clearly. Start by collecting your current symptoms and how long you have experienced them. Write down how many times per night you wake to urinate, how often you feel the urge to urinate during the day, whether your urine stream feels weak or slow, and how much these symptoms affect your daily activities and quality of life. This symptom history is medically relevant and helps your urologist understand the severity of your condition.

Gather your complete medication history, including any BPH medications you currently take or have taken in the past. If you have taken alpha-blockers like tamsulosin or alfuzosin, or 5-alpha reductase inhibitors like finasteride or dutasteride, document how long you took them and whether they improved your symptoms. If you took medications and stopped, note why you stopped—whether side effects occurred, the medication was not effective, or you chose to discontinue for another reason. This information directly relates to Medicare's requirement that you have tried or declined medical management.

Collect any previous urological test results or imaging studies. If you have had a prostate ultrasound, urinalysis, post-void residual measurement,